Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation

Circulation Research

Volumn 103, Issue 12, 2008, Pages 1402-1409

  Kawakami, Akio ^a   Osaka, Mizuko ^a   Aikawa, Masanori ^b   Uematsu, Satoshi ^c   Akira, Shizuo ^c   Libby, Peter ^b   Shimokado, Kentaro ^a   Sacks, Frank M ^b,d   Yoshida, Masayuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apolipoprotein; Atherosclerosis; Inflammation; Monocyte; Toll like receptor

Indexed keywords

APOLIPOPROTEIN C3; BETA1 INTEGRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN B; LIGAND; TLR2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN; WILD TYPE; ANIMAL; C57BL MOUSE; CELL LINE; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CELL LINE; HUMANS; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; PROTEIN BINDING; TOLL-LIKE RECEPTOR 2;

EID: 58149381764     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.178426     Document Type: Article

References (27)

1. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005;115:3149-3156.
2. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004;430:257-263.
3. Tobias P, Curtiss LK. Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res. 2005;46:404-411.
4. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101:10679-10684.
5. Yang QW, Mou L, Lv FL, Wang JZ, Wang L, Zhou HJ, Gao D. Role of Toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL. Biorheology. 2005; 42:225-236.
6. Harokopakis E, Albzreh MH, Martin MH, Hajishengallis G. TLR2 transmodulates monocyte adhesion and transmigration via Rac1-and PI3K-mediated inside-out signaling in response to Porphyromonas gin-givalis fimbriae. J Immunol. 2006;176:7645-7656.
7. Nakamura N, Yoshida M, Umeda M, Huang Y, Kitajima S, Inoue Y, Ishikawa I, Iwai T. Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis. 2008;196:59-67.
8. Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation. 2000;102:1886-1892.
9. Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation. 2006;113:691-700. (Pubitemid 43754333)
10. Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation. 2006;114:681-687.
11. Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM. Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein-and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol. 2007;27:219-225.
12. Kawakami A, Tanaka A, Nakajima K, Shimokado K, Yoshida M. Ator-vastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res. 2002;91:263-271.
13. Leon B, Martinez del Hoyo G, Parrillas V, Vargas HH, Sanchez-Mateos P, Longo N, Lopez-Bravo M, Ardavin C. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8 - and CD8+ splenic dendritic cells. Blood. 2004;103:2668-2676.
14. Yoshida M, Sawada T, Ishii H, Gerszten RE, Rosenzweig A, Gimbrone MA Jr, Yasukochi Y, Numano F. HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. Arterioscler Thromb Vasc Biol. 2001;21:1165-1171.
15. Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation. 2003;108:2679-2688.
16. Lee SJ, Campos H, Moye LA, Sacks FM. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol. 2003;23:853-858.
17. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macro-phage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 2003;278:1561-1568.
18. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004; 16:3-9.
19. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol. 2000;1: 533-540.
20. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816-825.
21. Lu Y, Morley P, Durkin JP. Signalling events mediating the activation of protein kinase C by interleukin-2 in cytotoxic T cells. Cell Signal. 1999; 11:275-285.
22. Melien O, Sandnes D, Johansen EJ, Christoffersen T. Effects of pertussis toxin on extracellular signal-regulated kinase activation in hepatocytes by hormones and receptor-independent agents: evidence suggesting a stimulatory role of Gi proteins at a level distal to receptor coupling. J Cell Physiol. 2000;184:27-36.
23. Wheeler-Jones CPD. Cell signalling in the cardiovascular system: an overview. Heart. 2005;91:1366-1374.
24. Luo SF, Wang CC, Chiu CT, Chien CS, Hsiao LD, Lin CH, Yang CM. Lipopolysaccharide enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells. Br J Pharmacol. 2000;130:1799-1808.
25. Lee CW, Chien CS, Yang CM. Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2004;286:L921-L930.
26. Lattin J, Zidar DA, Schroder K, Kellie S, Hume DA, Sweet MJ. G-protein-coupled receptor expression, function, and signaling in macro-phages. J Leukoc Biol. 2007;82:16-32.
27. Campos H, Perlov D, Khoo C, Sacks FM. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res. 2001;42:1239-1249.